Cardiac physiology in transgenic mice

Jeanne F. James, Timothy Hewett, Jeffrey Robbins

Research output: Contribution to journalShort survey

144 Citations (Scopus)

Abstract

By use of gene targeting and/or transgenesis, it is now possible to make defined changes in genes whose functions underlie mammalian cardiovascular function. Because of technical and economic considerations, these experiments are largely confined to the mouse. Genetic modification of the loci responsible for aspects of cardiac development, differentiation, and function via gene targeting, as well as modulation of the cardiac protein complement using transgenesis, has begun to provide mouse models of cardiac hypertrophy, dilated cardiomyopathy, and hypertrophic cardiomyopathies. In order to use these animal models fully and explore their phenotypes at the whole organ and whole animal levels, the extension of cardiovascular physiological methodologies to the mouse is imperative. Techniques for exploring aspects of cardiovascular function are well developed for larger animal models, but their modification for the small size of the mouse heart and for the animal's rapid cardiac cycle has proven to be a formidable challenge, requiring the combined efforts of the molecular biology, physiology, and cardiology communities. We review here the ability of present-day technology to obtain reproducible data on murine cardiac function at the whole organ and animal levels.

Original languageEnglish (US)
Pages (from-to)407-415
Number of pages9
JournalCirculation Research
Volume82
Issue number4
StatePublished - Mar 9 1998
Externally publishedYes

Fingerprint

Transgenic Mice
Animal Structures
Gene Transfer Techniques
Gene Targeting
Animal Models
Genetic Loci
Hypertrophic Cardiomyopathy
Dilated Cardiomyopathy
Cardiomegaly
Cardiology
Molecular Biology
Complement System Proteins
Economics
Technology
Phenotype
Genes

Keywords

  • Gene
  • Heart
  • Physiology
  • Transgenesis

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

James, J. F., Hewett, T., & Robbins, J. (1998). Cardiac physiology in transgenic mice. Circulation Research, 82(4), 407-415.

Cardiac physiology in transgenic mice. / James, Jeanne F.; Hewett, Timothy; Robbins, Jeffrey.

In: Circulation Research, Vol. 82, No. 4, 09.03.1998, p. 407-415.

Research output: Contribution to journalShort survey

James, JF, Hewett, T & Robbins, J 1998, 'Cardiac physiology in transgenic mice', Circulation Research, vol. 82, no. 4, pp. 407-415.
James JF, Hewett T, Robbins J. Cardiac physiology in transgenic mice. Circulation Research. 1998 Mar 9;82(4):407-415.
James, Jeanne F. ; Hewett, Timothy ; Robbins, Jeffrey. / Cardiac physiology in transgenic mice. In: Circulation Research. 1998 ; Vol. 82, No. 4. pp. 407-415.
@article{9ae3df629fae477499631c57f3dd43c8,
title = "Cardiac physiology in transgenic mice",
abstract = "By use of gene targeting and/or transgenesis, it is now possible to make defined changes in genes whose functions underlie mammalian cardiovascular function. Because of technical and economic considerations, these experiments are largely confined to the mouse. Genetic modification of the loci responsible for aspects of cardiac development, differentiation, and function via gene targeting, as well as modulation of the cardiac protein complement using transgenesis, has begun to provide mouse models of cardiac hypertrophy, dilated cardiomyopathy, and hypertrophic cardiomyopathies. In order to use these animal models fully and explore their phenotypes at the whole organ and whole animal levels, the extension of cardiovascular physiological methodologies to the mouse is imperative. Techniques for exploring aspects of cardiovascular function are well developed for larger animal models, but their modification for the small size of the mouse heart and for the animal's rapid cardiac cycle has proven to be a formidable challenge, requiring the combined efforts of the molecular biology, physiology, and cardiology communities. We review here the ability of present-day technology to obtain reproducible data on murine cardiac function at the whole organ and animal levels.",
keywords = "Gene, Heart, Physiology, Transgenesis",
author = "James, {Jeanne F.} and Timothy Hewett and Jeffrey Robbins",
year = "1998",
month = "3",
day = "9",
language = "English (US)",
volume = "82",
pages = "407--415",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Cardiac physiology in transgenic mice

AU - James, Jeanne F.

AU - Hewett, Timothy

AU - Robbins, Jeffrey

PY - 1998/3/9

Y1 - 1998/3/9

N2 - By use of gene targeting and/or transgenesis, it is now possible to make defined changes in genes whose functions underlie mammalian cardiovascular function. Because of technical and economic considerations, these experiments are largely confined to the mouse. Genetic modification of the loci responsible for aspects of cardiac development, differentiation, and function via gene targeting, as well as modulation of the cardiac protein complement using transgenesis, has begun to provide mouse models of cardiac hypertrophy, dilated cardiomyopathy, and hypertrophic cardiomyopathies. In order to use these animal models fully and explore their phenotypes at the whole organ and whole animal levels, the extension of cardiovascular physiological methodologies to the mouse is imperative. Techniques for exploring aspects of cardiovascular function are well developed for larger animal models, but their modification for the small size of the mouse heart and for the animal's rapid cardiac cycle has proven to be a formidable challenge, requiring the combined efforts of the molecular biology, physiology, and cardiology communities. We review here the ability of present-day technology to obtain reproducible data on murine cardiac function at the whole organ and animal levels.

AB - By use of gene targeting and/or transgenesis, it is now possible to make defined changes in genes whose functions underlie mammalian cardiovascular function. Because of technical and economic considerations, these experiments are largely confined to the mouse. Genetic modification of the loci responsible for aspects of cardiac development, differentiation, and function via gene targeting, as well as modulation of the cardiac protein complement using transgenesis, has begun to provide mouse models of cardiac hypertrophy, dilated cardiomyopathy, and hypertrophic cardiomyopathies. In order to use these animal models fully and explore their phenotypes at the whole organ and whole animal levels, the extension of cardiovascular physiological methodologies to the mouse is imperative. Techniques for exploring aspects of cardiovascular function are well developed for larger animal models, but their modification for the small size of the mouse heart and for the animal's rapid cardiac cycle has proven to be a formidable challenge, requiring the combined efforts of the molecular biology, physiology, and cardiology communities. We review here the ability of present-day technology to obtain reproducible data on murine cardiac function at the whole organ and animal levels.

KW - Gene

KW - Heart

KW - Physiology

KW - Transgenesis

UR - http://www.scopus.com/inward/record.url?scp=0032498785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032498785&partnerID=8YFLogxK

M3 - Short survey

VL - 82

SP - 407

EP - 415

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 4

ER -